About Event
Uniting The Entire Highly Potent Drug Development Value Chain – From Bench To Point of Outsource
Returning for the 8th year, the HPAPI Summit will unite process chemists and engineers with EHS, IH and toxicology professionals, presenting a unique opportunity to gain clarity on how you can enhance every stage of your potent compound development strategy.
Incorporating perspectives from more speakers than ever before and anticipating 120+ delegates, the 2019 conference is shaping up to be the comprehensive event of the series to date.
5 New Aspects for 2019:
- Calculate the ROI of EHS approaches
Learn from Allergan’s Dave Eherts, to understand approaches to calculate the ROI of various EHS approaches, enabling you to make radical improvements to the cost-effectiveness of your containment strategy
- Investigate regulatory strategies for novel potent compounds
Explore how Genentech implemented a novel regulatory strategy when introducing a novel high potency bispecific to a shared commercial facility, enabling you to learn how to successfully navigate the introduction of highly potent compounds into your own facilities
- Understand potent compound facility design as well as technology innovation
Gain insights into AbbVie and Nektar Therapeutics’ new potent compound facility designs, as well as data to support ILC Dover and ChargePoints’ containment technologies to gain holistic as well as specific containment perspectives
- Handle potent compounds at the lab scale
Overcome challenges involved in working with potent compounds in the early stages of development when limited data is available, enabling you to maintain safety and efficacy at every scale - Deep dive into best-practice potent compound training
A dedicated workshop session will define effective potent compound safety procedures and share how to measure their effectiveness, enabling you to make sure the proficiency of your operators matches the quality of the equipment they’re working with
“Great collection of speakers of different disciplines aligned on this important topic.”
Bob Sussman, Managing Director, SafeBridge
“I think this meeting is particularly useful in keeping abreast of EH&S and containment
trends in the industry. I also found it interesting to learn how other innovator companies
manage their HPAPI CMOs.”
Neil Faiber, Outsourcing Manager, Takeda